We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Diaphragmatic Movement Before and After Stellate Ganglion Block : A Ultrasonographic Study

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01054378
Recruitment Status : Completed
First Posted : January 22, 2010
Last Update Posted : December 7, 2010
Information provided by:
Yonsei University

Brief Summary:
The temporary diaphrgmatic dysfunction will occur after stellate ganglion block(SGB) and will be easily detected by M-mode ultrasonography

Condition or disease Intervention/treatment Phase
Head Pain Neck Pain Shoulder Pain Arm Pain Neural Sensory Hearing Loss Procedure: M-mode ultrasonography Phase 4

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 43 participants
Primary Purpose: Treatment
Study Start Date : January 2010
Primary Completion Date : March 2010
Study Completion Date : April 2010

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Ultrasound
U.S. FDA Resources

Intervention Details:
    Procedure: M-mode ultrasonography
    Evaluation of diaphragmatic movement using M-mode ultrasonography before and after stellate ganglion block with 1% lidocaine

Primary Outcome Measures :
  1. The amplitude of diaphragm movement before and after SGB during quiet breathing, deep breathing and voluntary sniff, inspiratory time and expiratory time, oxygen saturation [ Time Frame: The ultrasonographic evaluation will take place just before and 30 minutes after stellate ganglion block. ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   20 Years to 65 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • ASA class I-II patients who have head and neck pain or shoulder pain or sudden sensory neural hearing loss

Exclusion Criteria:

  • coagulopathy, pulmonary disease, neuropathy

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01054378

Korea, Republic of
Severance Hospital, Yonsei University College of Medicine
Seoul, Korea, Republic of
Sponsors and Collaborators
Yonsei University
Principal Investigator: Duck Mi Yoon Department of Anesthesiology and Pain Medicine, Yonsei University College of Medicine, Seoul, Korea

Responsible Party: Duck Mi Yoon/Professor of Anesthesiology and Pain Medicine,, Yonsei University College of Medicine, Seoul, South Korea,
ClinicalTrials.gov Identifier: NCT01054378     History of Changes
Other Study ID Numbers: 4-2009-0614
First Posted: January 22, 2010    Key Record Dates
Last Update Posted: December 7, 2010
Last Verified: December 2010

Additional relevant MeSH terms:
Neck Pain
Hearing Loss
Shoulder Pain
Hearing Loss, Sensorineural
Neurologic Manifestations
Nervous System Diseases
Signs and Symptoms
Hearing Disorders
Ear Diseases
Otorhinolaryngologic Diseases
Sensation Disorders
Joint Diseases
Musculoskeletal Diseases